105 related articles for article (PubMed ID: 38490194)
1. Development of MKK4 inhibitors for liver regeneration.
Hindson J
Nat Rev Gastroenterol Hepatol; 2024 Jun; 21(6):376. PubMed ID: 38750267
[No Abstract] [Full Text] [Related]
2. Prometheus 2.0: drug-induced liver regeneration arising.
Tchorz JS
Cell Res; 2024 Apr; ():. PubMed ID: 38684779
[No Abstract] [Full Text] [Related]
3. Critical Role of LSEC in Post-Hepatectomy Liver Regeneration and Failure.
De Rudder M; Dili A; Stärkel P; Leclercq IA
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360818
[TBL] [Abstract][Full Text] [Related]
4. New paradigms in post-hepatectomy liver failure.
Golse N; Bucur PO; Adam R; Castaing D; Sa Cunha A; Vibert E
J Gastrointest Surg; 2013 Mar; 17(3):593-605. PubMed ID: 23161285
[TBL] [Abstract][Full Text] [Related]
5. First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure.
Zwirner S; Abu Rmilah AA; Klotz S; Pfaffenroth B; Kloevekorn P; Moschopoulou AA; Schuette S; Haag M; Selig R; Li K; Zhou W; Nelson E; Poso A; Chen H; Amiot B; Jia Y; Minshew A; Michalak G; Cui W; Rist E; Longerich T; Jung B; Felgendreff P; Trompak O; Premsrirut PK; Gries K; Muerdter TE; Heinkele G; Wuestefeld T; Shapiro D; Weissbach M; Koenigsrainer A; Sipos B; Ab E; Zacarias MO; Theisgen S; Gruenheit N; Biskup S; Schwab M; Albrecht W; Laufer S; Nyberg S; Zender L
Cell; 2024 Mar; 187(7):1666-1684.e26. PubMed ID: 38490194
[TBL] [Abstract][Full Text] [Related]
6. Human Stem Cells Promote Liver Regeneration After Partial Hepatectomy in BALB/C Nude Mice.
Wabitsch S; Benzing C; Krenzien F; Splith K; Haber PK; Arnold A; Nösser M; Kamali C; Hermann F; Günther C; Hirsch D; Sauer IM; Pratschke J; Schmelzle M
J Surg Res; 2019 Jul; 239():191-200. PubMed ID: 30844633
[TBL] [Abstract][Full Text] [Related]
7. Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy.
Fouraschen SM; Pan Q; de Ruiter PE; Farid WR; Kazemier G; Kwekkeboom J; Ijzermans JN; Metselaar HJ; Tilanus HW; de Jonge J; van der Laan LJ
Stem Cells Dev; 2012 Sep; 21(13):2410-9. PubMed ID: 22455365
[TBL] [Abstract][Full Text] [Related]
8. Preconditioning by portal vein embolization modulates hepatic hemodynamics and improves liver function in pigs with extended hepatectomy.
Asencio JM; García-Sabrido JL; López-Baena JA; Olmedilla L; Peligros I; Lozano P; Morales-Taboada Á; Fernández-Mena C; Steiner MA; Sola E; Perez-Peña JM; Herrero M; Laso J; Lisbona C; Bañares R; Casanova J; Vaquero J
Surgery; 2017 Jun; 161(6):1489-1501. PubMed ID: 28117095
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration.
Pfaffenrot B; Klövekorn P; Juchum M; Selig R; Albrecht W; Zender L; Laufer SA
Eur J Med Chem; 2021 Jun; 218():113371. PubMed ID: 33794385
[TBL] [Abstract][Full Text] [Related]
10. A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration.
Wuestefeld T; Pesic M; Rudalska R; Dauch D; Longerich T; Kang TW; Yevsa T; Heinzmann F; Hoenicke L; Hohmeyer A; Potapova A; Rittelmeier I; Jarek M; Geffers R; Scharfe M; Klawonn F; Schirmacher P; Malek NP; Ott M; Nordheim A; Vogel A; Manns MP; Zender L
Cell; 2013 Apr; 153(2):389-401. PubMed ID: 23582328
[TBL] [Abstract][Full Text] [Related]
11. MetaboLights: open data repository for metabolomics.
Yurekten O; Payne T; Tejera N; Amaladoss FX; Martin C; Williams M; O'Donovan C
Nucleic Acids Res; 2024 Jan; 52(D1):D640-D646. PubMed ID: 37971328
[TBL] [Abstract][Full Text] [Related]
12. JNKs protect from cholestatic liver disease progression by modulating Apelin signalling.
Mohamed MR; Haybaeck J; Wu H; Su H; Bartneck M; Lin C; Boekschoten MV; Boor P; Goeppert B; Rupp C; Strnad P; Davis RJ; Cubero FJ; Trautwein C
JHEP Rep; 2023 Nov; 5(11):100854. PubMed ID: 37791376
[TBL] [Abstract][Full Text] [Related]
13. Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation.
Nies AT; König J; Leuthold P; Damme K; Winter S; Haag M; Masuda S; Kruck S; Daniel H; Spanier B; Fromm MF; Bedke J; Inui KI; Schwab M; Schaeffeler E
Pharmacol Res; 2023 Oct; 196():106941. PubMed ID: 37775020
[TBL] [Abstract][Full Text] [Related]
14. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Rinella ME; Lazarus JV; Ratziu V; Francque SM; Sanyal AJ; Kanwal F; Romero D; Abdelmalek MF; Anstee QM; Arab JP; Arrese M; Bataller R; Beuers U; Boursier J; Bugianesi E; Byrne CD; Castro Narro GE; Chowdhury A; Cortez-Pinto H; Cryer DR; Cusi K; El-Kassas M; Klein S; Eskridge W; Fan J; Gawrieh S; Guy CD; Harrison SA; Kim SU; Koot BG; Korenjak M; Kowdley KV; Lacaille F; Loomba R; Mitchell-Thain R; Morgan TR; Powell EE; Roden M; Romero-Gómez M; Silva M; Singh SP; Sookoian SC; Spearman CW; Tiniakos D; Valenti L; Vos MB; Wong VW; Xanthakos S; Yilmaz Y; Younossi Z; Hobbs A; Villota-Rivas M; Newsome PN;
J Hepatol; 2023 Dec; 79(6):1542-1556. PubMed ID: 37364790
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
